HIV Envelope Glycoform Heterogeneity and Localized Diversity Govern the Initiation and Maturation of a V2 Apex Broadly Neutralizing Antibody Lineage.
Landais, E., Murrell, B., Briney, B., Murrell, S., Rantalainen, K., Berndsen, Z.T., Ramos, A., Wickramasinghe, L., Smith, M.L., Eren, K., de Val, N., Wu, M., Cappelletti, A., Umotoy, J., Lie, Y., Wrin, T., Algate, P., Chan-Hui, P.Y., Karita, E., Ward, A.B., Wilson, I.A., Burton, D.R., Smith, D., Pond, S.L.K., Poignard, P.(2017) Immunity 47: 990-1003.e9
- PubMed: 29166592 
- DOI: 10.1016/j.immuni.2017.11.002
- Primary Citation of Related Structures:  
5FEH - PubMed Abstract: 
Understanding how broadly neutralizing antibodies (bnAbs) to HIV envelope (Env) develop during natural infection can help guide the rational design of an HIV vaccine. Here, we described a bnAb lineage targeting the Env V2 apex and the Ab-Env co-evolution that led to development of neutralization breadth ...